Role of Imaging in the Detection of Reversible Cardiomyopathy

키워드

참고문헌 (99)

1. McMurray JJ, "Clinical practice. Systolic heart failure", N Engl J Med, 362, pp.228~238 (2010)
2. Jessup M, "Heart failure", N Engl J Med, 348, pp.2007~2018 (2003)
3. Ghali JK, "Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence", Arch Intern Med, 150, pp.769~773 (1990)
4. McNamara DM, "Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study", J Am Coll Cardiol, 58, pp.1112~1118 (2011)
5. Hunt SA, "2009 focused update incorporated into the ACC", AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation, Circulation, pp.2009, 119[DOI]
6. Senni M, "Use of echocardiography in the management of congestive heart failure in the community", J Am Coll Cardiol, 33, pp.164~170 (1999)
7. Douglas PS, "American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group; American Society of Echocardiography; American College of Emergency Physicians; American Society of Nuclear Cardiology; Society for Cardiovascular Angiography and Interventions; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American College of Chest Physicians; Society of Critical Care Medicine. ACCF", ASE, ASNC, pp.SCAI, SCCT[DOI]
8. Otterstad JE, "Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function", Eur Heart J, 18, pp.507~513 (1997)
9. Afridi I, "Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty", Circulation, 91, pp.663~670 (1995)
10. Tsuchihashi K, "Angina Pectoris-Myocardial Infarction Investigations in Japan. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan", J Am Coll Cardiol, 38, pp.11~18 (2001)
11. Sharkey SW, "Acute and reversible cardiomyopathy provoked by stress in women from the United States", Circulation, 111, pp.472~479 (2005)
12. Mahrholdt H, "Reproducibility of chronic infarct size measurement by contrast- enhanced magnetic resonance imaging", Circulation, 106, pp.2322~2327 (2002)
13. Kilner PJ, "Flow measurement by magnetic resonance: a unique asset worth optimising", J Cardiovasc Magn Reson, 9, pp.723~728 (2007)
14. Mahrholdt H, "Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies", Eur Heart J, 26, pp.1461~1474 (2005)
15. Mahrholdt H, "Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology", Circulation, 109, pp.1250~1258 (2004)
16. Assomull RG, "Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology", Circulation, 124, pp.1351~1360 (2011)
17. Aletras AH, "Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations", Circulation, 113, pp.1865~1870 (2006)
18. Abdel-Aty H, "Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches", J Am Coll Cardiol, 45, pp.1815~1822 (2005)
19. Kellman P, "T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo", Magn Reson Med, 57, pp.891~897 (2007)
20. Blume U, "Interleaved T(1) and T(2) relaxation time mapping for cardiac applications", J Magn Reson Imaging, 29, pp.480~487 (2009)
21. Sparrow P, "Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study", AJR Am J Roentgenol, 187, pp.W630~W635 (2006)
22. Felker GM, "Underlying causes and longterm survival in patients with initially unexplained cardiomyopathy", N Engl J Med, 342, pp.1077~1084 (2000)
23. Friedrich MG, "International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper", J Am Coll Cardiol, 53, pp.1475~1487 (2009)
24. McCarthy RE 3rd, "Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis", N Engl J Med, 342, pp.690~695 (2000)
25. Felker GM, "Echocardiographic findings in fulminant and acute myocarditis", J Am Coll Cardiol, 36, pp.227~232 (2000)
26. Pearson GD, "Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review", JAMA, 283, pp.1183~1188 (2000)
27. Martin JA, "Annual summary of vital statistics: 2006", Pediatrics, 121, pp.788~801 (2008)
28. Witlin AG, "Peripartum cardiomyopathy: a longitudinal echocardiographic study", Am J Obstet Gynecol, 177, pp.1129~1132 (1997)
29. Cooper LT, "IMAC2 Investigators. Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women", J Card Fail, 18, pp.28~33 (2012)
30. Barone-Rochette G, "Value of cardiac MRI in peripartum cardiomyopathy", Arch Cardiovasc Dis, 104, pp.263~264 (2011)
31. Kawano H, "Magnetic resonance imaging in a patient with peripartum cardiomyopathy", Intern Med, 47, pp.97~102 (2008)
32. Sliwa K, "Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study", Circulation, 121, pp.1465~1473 (2010)
33. Elkayam U, "Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy", N Engl J Med, 344, pp.1567~1571 (2001)
34. Pavin D, "Human stress cardiomyopathy mimicking acute myocardial syndrome", Heart, 78, pp.509~511 (1997)
35. Park JH, "Left ventricular apical ballooning due to severe physical stress in patients admitted to the medical ICU", Chest, 128, pp.296~302 (2005)
36. Hurst RT, "Transient midventricular ballooning syndrome: a new variant", J Am Coll Cardiol, 48, pp.579~583 (2006)
37. Kawai S, "Takotsubo Cardiomyopathy Group. Guidelines for diagnosis of takotsubo (ampulla) cardiomyopathy", Circ J, 71, pp.990~992 (2007)
38. Haghi D, "Right ventricular involvement in Takotsubo cardiomyopathy", Eur Heart J, 27, pp.2433~2439 (2006)
39. Haghi D, "Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy)", Int J Cardiol, 120, pp.205~211 (2007)
40. Eitel I, "Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy", JAMA, 306, pp.277~286 (2011)
41. Abdel-Aty H, "Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance", Int J Cardiol, 132, pp.291~293 (2009)
42. 신성균, "A Case of Acute ST-Segment Elevation Myocardial Infarction Mimicking Stress Induced Cardiomyopathy; Demonstration of Typical Echocardiographic Finding Correlated with Unusual Distribution of Left Anterior Descending Coronary Artery", Journal of Cardiovascular Ultrasound, 18(3), pp.101~103 (2010), 한국심초음파학회
43. Haft JI, "Cardiovascular injury induced by sympathetic catecholamines", Prog Cardiovasc Dis, 17, pp.73~86 (1974)
44. 김은미, "Catecholamines May Play an Important Role in the Pathogenesis of Transient Mid- and Basal Ventricular Ballooning Syndrome", Journal of Korean Medical Science, 23(5), pp.898~902 (2008), 대한의학회
45. Jacobs LJ, "Reversible dilated cardiomyopathy induced by methamphetamine", Clin Cardiol, 12, pp.725~727 (1989)
46. Imperato-McGinley J, "Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma", N Engl J Med, 316, pp.793~797 (1987)
47. 박재형, "Prevalence and Patterns of Left Ventricular Dysfunction in Patients with Pheochromocytoma", Journal of Cardiovascular Ultrasound, 19(2), pp.76~82 (2011), 한국심초음파학회
48. Lam JB, "Reversible dilatation of hypertrophied left ventricle in pheochromocytoma: serial two-dimensional echocardiographic observations", Am Heart J, 109(3 Pt 1), pp.613~615 (1985)
49. Roghi A, "Adrenergic myocarditis in pheochromocytoma", J Cardiovasc Magn Reson, 13, pp.4~ (2011)
50. Woeber KA, "Thyrotoxicosis and the heart", N Engl J Med, 327, pp.94~98 (1992)
51. Levey GS, "Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism", Am J Med, 88, pp.642~646 (1990)
52. Dahl P, "Thyrotoxic cardiac disease", Curr Heart Fail Rep, 5, pp.170~176 (2008)
53. Radhakrishnan A, "An association between Takotsubo cardiomyopathy and thyroid storm", Postgrad Med, 121, pp.126~130 (2009)
54. Thebault C, "A case of thyroid storm following radioiodine therapy underlying usefulness of cardiac MRI", Eur J Intern Med, 20, pp.e136~e137 (2009)
55. Derish M, "Reversible cardiomyopathy in a child with Addison’s disease", Intensive Care Med, 22, pp.460~463 (1996)
56. Bouachour G, "Hemodynamic changes in acute adrenal insufficiency", Intensive Care Med, 20, pp.138~141 (1994)
57. Legrand V, "Dramatic improvement of severe dilated cardiomyopathy in an acromegalic patient after treatment with octreotide and trans-sphenoidal surgery", Eur Heart J, 15, pp.1286~1289 (1994)
58. Gouya H, "Rapidly reversible myocardial edema in patients with acromegaly: assessment with ultrafast T2 mapping in a single-breath-hold MRI sequence", AJR Am J Roentgenol, 190, pp.1576~1582 (2008)
59. Frustaci A, "Reversible dilated cardiomyopathy due to growth hormone deficiency", Am J Clin Pathol, 97, pp.503~511 (1992)
60. Shinbane JS, "Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies", J Am Coll Cardiol, 29, pp.709~715 (1997)
61. Moe GW, "Early recovery from heart failure: insights into the pathogenesis of experimental chronic pacing- induced heart failure", J Lab Clin Med, 112, pp.426~432 (1988)
62. Chugh SS, "First evidence of premature ventricular complex-induced cardiomyopathy: a potentially reversible cause of heart failure", J Cardiovasc Electrophysiol, 11, pp.328~329 (2000)
63. Umana E, "Tachycardia-induced cardiomyopathy", Am J Med, 114, pp.51~55 (2003)
64. Redfield MM, "Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation", Mayo Clin Proc, 75, pp.790~795 (2000)
65. Nerheim P, "Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia", Circulation, 110, pp.247~252 (2004)
66. Clark DM, "Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation", J Am Coll Cardiol, 30, pp.1039~1045 (1997)
67. Darsee JR, "Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia", Ann Intern Med, 89, pp.867~870 (1978)
68. Shimon I, "Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy", Am J Med, 98, pp.485~490 (1995)
69. Hanninen SA, "The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure", J Am Coll Cardiol, 47, pp.354~361 (2006)
70. Park JH, "Thiamine deficiency as a rare cause of reversible severe pulmonary hypertension", Int J Cardiol, 121, pp.e1~e3 (2007)
71. Koike H, "Myopathy in thiamine deficiency: analysis of a case", J Neurol Sci, 249, pp.175~179 (2006)
72. Bashour T, "Hypocalcemic cardiomyopathy", Chest, 78, pp.663~665 (1980)
73. Ino T, "Cardiac manifestations in disorders of fat and carnitine metabolism in infancy", J Am Coll Cardiol, 11, pp.1301~1308 (1988)
74. Helton E, "Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy", Pediatrics, 105, pp.1260~1270 (2000)
75. Reeves WC, "Reversible cardiomyopathy due to selenium deficiency", JPEN J Parenter Enteral Nutr, 13, pp.663~665 (1989)
76. Rahko PS, "Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload", J Am Coll Cardiol, 8, pp.436~440 (1986)
77. Nakamura M, "Reversible restrictive cardiomyopathy due to lightchain deposition disease", Mayo Clin Proc, 77, pp.193~196 (2002)
78. Keefe DL, "Anthracycline-induced cardiomyopathy", Semin Oncol, 28(4 Suppl 12), pp.2~7 (2001)
79. Regan TJ, "Alcoholic cardiomyopathy", Prog Cardiovasc Dis, 27, pp.141~152 (1984)
80. Demakis JG, "The natural course of alcoholic cardiomyopathy", Ann Intern Med, 80, pp.293~297 (1974)
81. Matsui Y, "Clinicopathological study of fatal myocardial sarcoidosis", Ann N Y Acad Sci, 278, pp.455~469 (1976)
82. Silverman KJ, "Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis", Circulation, 58, pp.1204~1211 (1978)
83. Baughman RP, "Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis", Am J Respir Crit Care Med, 164(10 Pt 1), pp.1885~1889 (2001)
84. Roberts WC, "Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)", Am J Med, 63, pp.86~108 (1977)
85. Burstow DJ, "Twodimensional echocardiographic findings in systemic sarcoidosis", Am J Cardiol, 63, pp.478~482 (1989)
86. Gibbons WJ, "Subclinical cardiac dysfunction in sarcoidosis", Chest, 100, pp.44~50 (1991)
87. Smedema JP, "Evaluation of the accuracy of gadolinium- enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis", J Am Coll Cardiol, 45, pp.1683~1690 (2005)
88. Chiu CZ, "Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis", Am J Cardiol, 95, pp.143~146 (2005)
89. Chapelon-Abric C, "Cardiac sarcoidosis: a retrospective study of 41 cases", Medicine (Baltimore), 83, pp.315~334 (2004)
90. Satran D, "Cardiovascular manifestations of moderate to severe carbon monoxide poisoning", J Am Coll Cardiol, 45, pp.1513~1516 (2005)
91. Ahn KT, "Prevalence and clinical outcomes of left ventricular systolic dysfunction after carbon monoxide exposure", Int J Cardiol, 153, pp.108~110 (2011)
92. Henry TD, "Myocardial fibrosis from severe carbon monoxide poisoning detected by cardiac magnetic resonance imaging", Circulation, 118, pp.792~ (2008)
93. Chokshi SK, "Reversible cardiomyopathy associated with cocaine intoxication", Ann Intern Med, 111, pp.1039~1040 (1989)
94. Robaei D, "Cocaineinduced epicardial coronary artery thrombosis resulting in extensive myocardial injury assessed by cardiac magnetic resonance imaging", Eur Heart J, 31, pp.2446~ (2010)
95. Hering SE, "Reversible cardiomyopathy in patients with severe scorpion envenoming by Tityus serrulatus: evolution of enzymatic, electrocardiographic and echocardiographic alterations", Ann Trop Paediatr, 13, pp.173~182 (1993)
96. Sonnenblick M, "Reversible cardiomyopathy induced by interferon", BMJ, 300, pp.1174~1175 (1990)
97. Ting JY, "Reversible cardiomyopathy associated with acute inhaled marijuana use in a young adult", Clin Toxicol (Phila), 45, pp.432~434 (2007)
98. Goel M, "Reversible cardiomyopathy after high-dose interleukin-2 therapy", J Immunother (1991), 11, pp.225~229 (1992)
99. Hunt SA, "American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC", AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology, J Am Coll Cardiol, pp.2005, 46[DOI]

관련 논문AI추천